IPOPLUS

₹144.91

▼ -2.45 -1.66%

18 Jun 2026

NSE Listed · Healthcare

GPT Healthcare Limited (GPTHEALTH)

Volume: 5,766Avg Vol 1W: 15,539Avg Vol 1M: 75,72652W Range:₹115₹185
NSE BSE
₹144.91▼ 1.66%
Key Ratios
Updated 1h ago
Market Cap—
Current Price₹144.91
Previous Close₹147.36
High / Low (52w)₹185 / ₹115
Volume5,766
Avg Vol (1W)15,539
Avg Vol (1M)75,726
Stock P/E—
Book Value₹32.84
Dividend Yield—
ROE—
ROA—
Revenue (TTM)—
Revenue Growth39%
Profit Margin—
Total Debt₹72 Cr
Shares Outstanding—
Face Value₹10
EPS (TTM)₹1.78
P/B4.34
Debt / Equity—
50 DMA₹144.18
200 DMA₹133.06
Day change-1.66%
Price Chart
₹144.91▼ 2.90% · 1Y
₹155₹11511.0L
2025-10-20
2026-06-16

20-day avg volume: 81K shares

Quarterly Results
MetricMar 2026Dec 2025Sept 2025Jun 2025Mar 2025Dec 2024Sept 2024Jun 2024Mar 2024Dec 2023Sept 2023Jun 2023Mar 2023Dec 2022Jun 2022
Revenue₹126 Cr₹120 Cr₹119 Cr₹107 Cr₹101 Cr₹102 Cr₹106 Cr₹98 Cr₹99 Cr₹97 Cr₹108 Cr₹96 Cr₹96 Cr₹93 Cr₹82 Cr
EBITDA₹18 Cr₹15 Cr₹17 Cr₹13 Cr₹17 Cr₹18 Cr₹21 Cr₹16 Cr₹20 Cr₹18 Cr₹21 Cr₹16 Cr₹22 Cr₹17 Cr₹13 Cr
Net Profit₹15 Cr₹9 Cr₹11 Cr₹8 Cr₹13 Cr₹12 Cr₹15 Cr₹10 Cr₹13 Cr₹11 Cr₹14 Cr₹10 Cr₹10 Cr₹8 Cr₹8 Cr
EPS1.781.141.290.941.571.491.811.211.591.441.691.251.31.050.96
Profit & Loss (Annual)
MetricMar 2025Mar 2024Mar 2023Mar 2022Mar 2021Mar 2020
Revenue₹416 Cr₹405 Cr₹367 Cr₹342 Cr₹249 Cr₹216 Cr
EBITDA₹73 Cr₹75 Cr₹65 Cr₹65 Cr₹43 Cr₹29 Cr
Net Profit₹50 Cr₹48 Cr₹39 Cr₹42 Cr₹21 Cr₹11 Cr
EPS6.085.964.885.227.924.11
Balance Sheet
MetricMar 2025Mar 2024Mar 2023Mar 2022Mar 2021Mar 2020
Total Assets₹384 Cr₹346 Cr₹327 Cr₹323 Cr₹317 Cr₹308 Cr
Total Liabilities₹136 Cr₹127 Cr₹161 Cr₹165 Cr₹183 Cr₹182 Cr
Equity₹248 Cr₹218 Cr₹165 Cr₹158 Cr₹134 Cr₹127 Cr
Total Debt₹6 Cr₹4 Cr₹40 Cr₹72 Cr₹102 Cr₹96 Cr
Cash Flow
MetricMar 2025Mar 2024Mar 2023Mar 2022Mar 2021Mar 2020
Operating₹84 Cr₹84 Cr₹77 Cr₹79 Cr₹40 Cr₹42 Cr
Investing₹-33 Cr₹-25 Cr₹5 Cr₹-5 Cr₹-16 Cr₹-54 Cr
Financing₹-35 Cr₹-49 Cr₹-73 Cr₹-57 Cr₹-22 Cr₹12 Cr
Free Cash Flow₹84 Cr₹84 Cr₹77 Cr₹79 Cr₹40 Cr₹42 Cr
Shareholding
Promoter 65.57% Institutions 9.65% Public 24.78%

Prices are delayed/indicative; pros & cons are AI generated. Informational only — not investment advice. ← Back to search